This virtual symposium focuses on individualizing treatment for patients with ocular hypertension and primary open-angle glaucoma (POAG). In addition to case studies, Nathan M. Radcliffe, MD, and Mile Brujic, OD, FAAO, discuss monotherapy and combination regimens and compare which option is most likely to achieve each patient’s goal IOP.
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Upon completion of this activity, the participant should be able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsored by: 
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 123810, is accredited by COPE for continuing education for optometrists.
This course is approved for 1 hour of CE.
Course #78137-GL
Activity #123810
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Nathan M. Radcliffe, MD
Glaucoma Specialist
New York Eye Surgery Center
New York, NY
Mile Brujic, OD, FAAO
Premier Vision Group
Bowling Green, OH
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Nathan M. Radcliffe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon Vision, Alimera Sciences, Allergan, Bausch + Lomb, Beaver-Visitec International, Carl Zeiss Meditec, CATS, Ellex, ELT Sight, Equinox, Eyepoint Pharmaceuticals, Glaukos, Iridex, Ivantis/Kala Pharmaceuticals, Lumenis, New World Medical, Novartis, Ocular Science, Ocular Therapeutix, Omeros, Quantel Medical, Reichert, Santen, Shire Sight Sciences, Spyglass Thea, and ViaLase. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon Vision, Alimera Sciences, Allergan, Bausch + Lomb, Beaver-Visitec International, Eyepoint Pharmaceuticals, Glaukos, Iridex, Ivantis\Kala Pharmaceuticals, Lumenis, New World Medical, Novartis, Reichert, and Sight Sciences. Stock/Shareholder: CATS, ELT Sight, Equinox, Ivantis, Sight Sciences, and Spyglass.
Mile Brujic, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant/Grant Support/Research Support/Speaker’s List: ABB Optical, Alcon, Allergan, Art Optical, Bausch + Lomb, Contamac, CooperVision, CSEye, Horizon Therapeutics, Johnson & Johnson Vision, Kala, Lenstech, Novartis, Optovue, Oyster Point, RVL, Santen, Sun Pharmaceutical Industries, Tangible Science, Tarsus, Walman Optical, and Zea Vision.
The Evolve staff and planners have no financial relationships with ineligible companies.
Nisha Mukherjee, MD, peer reviewer, have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Yewlin E. Chee, MD
Camila Ventura MD, PhD
Edward Wood, MD
Tony Capone Jr, MD
Katherine E. Talcott, MD
Nassim Abreu, MD
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
